HopeStage
Back to all studies
RecruitingNCT07108257

Safety of focused ultrasound for treatment-resistant bipolar depression

About this title

Magnetic Resonance-Guided Focused Ultrasound Bilateral Capsulotomy for the Treatment of Refractory Bipolar Depression

Read the official source — NCT07108257
Device studyAges 18–65CanadaBipolarity
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 65 years.

Listed locations
TorontoSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: June 25, 2025
Recruitment status
Recruiting
Enrollment listed in the registry
10
Sponsor
Sunnybrook Health Sciences Centre
Sponsor type
Unknown or unclear
Study type
Device
Intervention type
Device
Locations
Canada
Age range
From 18 Years to 65 Years
Official registry ID
NCT07108257
Official title
Show the full official title

Phase I Trial of Magnetic Resonance-Guided Focused Ultrasound (MRgFUS) Bilateral Capsulotomy for the Treatment of Refractory Bipolar Depression

Recruitment & locations

Currently recruiting

Toronto

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Sunnybrook Health Sciences Centre.

Who can participate?

Listed age limits: 18 years to 65 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies